Hyderabad-Dr Reddy’s Laboratories, the marketing partner of Sputnik V Covid vaccine in India, developed by the Russian Direct Investment Fund (RDIF), on Saturday stated that efforts were on to produce the vaccine in five Indian sites with collaborative efforts.
This was informed to Telangana Governor Dr Tamilisai Soundararajan by the representatives from Dr Reddy’s Lab during a review meeting held on the progress in production and distribution of Sputnik-V vaccine and the 2DG drug through a video conference from Raj Bhavan, here.
The pharma giant representatives Kapil, Mallikarjuna Rao, Vemuri Vishwanath, and Ravi who interacted with the Governor during the review, said that they were confident to make 15 to 20 crore doses of vaccine available during the next six months through imports and manufacturing within the country.
“The equitable allocation of vaccines will be ensured to all the States in our country,” they added.
They informed the Governor that by the end of July, they would get 2 crore doses of vaccine consignments from Russia.
India has already received two consignments of vaccines from Russia. Inoculations with Sputnik V in Hyderabad started on May 14 following the arrival of the first batch of the vaccine on May 1.
Sputnik V was approved for use in India on April 12 and granted emergency use authorisation. India is the leading production hub for Sputnik V.
